Development of novel therapy for heart failure using Cdk9 as a target molecule
Development of novel therapy for heart failure using Cdk9 as a target molecule
批准号:
18390239
负责人:
SANO Motoaki
金额:
$11.36万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Intramolecular control of protein stability, subnuclear compartmentalization, and coactivator function of peroxisome proliferator-activated receptor gamma coactivator 1alphaPeroxisome proliferator-activated receptor gamma coactivator (PGC)-1 is a critical transcriptional regulator of energy metabolism. Here we found that PGC-1alpha is a short lived and aggregation-prone protein. PGC-1alpha localized throughout the nucleoplasm and was rapidly destroyed via the ubiquitin-proteasome pathway. Upon proteasome inhibition, PGC-1alpha formed insoluble polyubiquitinated aggregates. Ubiquitination of PGC-1alpha depended on the integrity of the C terminus-containing arginine-serine-rich domains and an RNA recognition motif. Interestingly, ectopically expressed C-terminal fragment of PGC-1alpha was autonomously ubiquitinated and aggregated with promyelocytic leukemia protein. Cooperation of the N-terminal region containing two PEST-like motifs was required for prevention of aggregation and targeti … More ng of the polyubiquitinated PGC-1alpha for degradation. This region thereby negatively controlled the aggregation properties of the C-terminal region to regulate protein turnover and intranuclear compartmentalization of PGC-1alpha Exogenous expression of the PGC-1alpha C-terminal fragment interfered with degradation of full-length PGC-1alpha and enhanced its coactivation properties. We concluded that PGC-1alpha function is critically regulated at multiple steps via intramolecular cooperation among several distinct structural domains of the protein.HEXIM-1 alleviated hypoxia-induced right ventricular hypertrophyHEXIM-1 is an endogenous inhibitor of Cdk9. To examine the effect of Cdk9 inhibition on the development of cardiac hypertrophy, we developed loss of function model of Cdk9 activity by transgenic over-expression of HEXIM-1. Cardiac-specific HEXIM-1 TG mice and wild-type littermates were subjected to hypoxia (11% O_2). Right ventricular hypertrophy produced by hypoxia was milder in HEXIM-1 TG mice compared to wild-type littermates. Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
転写共役因子PPARg coactivator-1(PGC-1)の細胞内局在とタンパクレベルの制御機構
转录共激活因子PPARg coactivator-1 (PGC-1)的亚细胞定位和蛋白水平控制机制
DOI:
--
发表时间:
2007
期刊:
影响因子:
--
作者:
[Ieda M, kanazawa H, Sano M, 佐野 元昭, Motoaki Sano, 佐野 元昭]
通讯作者:
佐野 元昭
DOI:
10.1161/circulationaha.106.650903
发表时间:
2007-09-04
期刊:
CIRCULATION
影响因子:
37.8
作者:
[Endo, Jin, Sano, Motoaki, Fukuda, Keiichi]
通讯作者:
Fukuda, Keiichi
Menage-a-trois 1 is indisoensable for the transcriptional function of PPARy coactivatior-1
Menage-a-trois 1 与 PPARy coactivatior-1 的转录功能密不可分
DOI:
--
发表时间:
2007
期刊:
Cell Metabolism 5
影响因子:
--
作者:
[Sano, M, Izumu, Y, et. al.]
通讯作者:
et. al.
ミトコンドリアと転写制御からみた循環器疾患
从线粒体和转录调控的角度看心血管疾病
DOI:
--
发表时间:
2006
期刊:
実験医学 増刊 疾患のサイエンス Vo1.24-No.10
影响因子:
--
作者:
[佐野元昭, 福田恵一]
通讯作者:
福田恵一
DOI:
10.1074/jbc.m703634200
发表时间:
2007-08-31
期刊:
JOURNAL OF BIOLOGICAL CHEMISTRY
影响因子:
4.8
作者:
[Sano, Motoaki, Tokudome, Satori, Fukuda, Keiichi]
通讯作者:
Fukuda, Keiichi
共 16 条
Elucidation of the molecular mechanism and regulation of T-cell senescence
-
批准号:18H02812
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.15万
-
财政年份:2018
-
负责人:SANO Motoaki
-
依托单位:
Cellular mechanism of cardio-adrenal interaction
-
批准号:25670396
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.41万
-
财政年份:2013
-
负责人:SANO Motoaki
-
依托单位:
PGD2-CRTH2 pathway promotes tubulointerstitial fibrosis
-
批准号:24659395
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.41万
-
财政年份:2012
-
负责人:SANO Motoaki
-
依托单位:
A significance of integrated stress response in the heart
-
批准号:22659158
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.07万
-
财政年份:2010
-
负责人:SANO Motoaki
-
依托单位:
A role of amino acid metabolism in the oxidative stress response
-
批准号:20390228
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.15万
-
财政年份:2008
-
负责人:SANO Motoaki
-
依托单位:
国内基金
海外基金
登录
查看更多内容
利用CRISPR内源性激活Atoh1转录促进前庭毛细胞再生和功能重建
-
批准号:82371145
-
项目类别:面上项目
-
资助金额:46.00万元
-
批准年份:2023
-
负责人:陶永
-
依托单位:
转录因子BCL6抑制ICOSL表达优化生发中心反应的机制研究
-
批准号:82371745
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:张文倩
-
依托单位:
转录因子LEF1低表达抑制HMGB1致子宫腺肌病患者子宫内膜容受性低下的分子机制
-
批准号:82371704
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:徐步芳
-
依托单位:
小鼠肺腺鳞癌转分化类器官模型的建立及表观调控分子机制研究
-
批准号:32100593
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:童欣媛
-
依托单位:
NFATc3转录调控MMP14介导少突胶质细胞瘤血管新生促肿瘤恶变的机制研究
-
批准号:32100563
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:齐琳
-
依托单位:
KLF5诱导小鼠始发态多能性干细胞向滋养层干细胞转变的作用与机制研究
-
批准号:32100596
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:黄颖华
-
依托单位:
锌指蛋白ZBTB17调控成纤维细胞衰老的机制研究
-
批准号:32000509
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:马兴杰
-
依托单位:
细胞衰老抑制直接重编程及心肌再生修复的分子机理研究
-
批准号:92068107
-
项目类别:重大研究计划
-
资助金额:79.0万元
-
批准年份:2020
-
负责人:王丽
-
依托单位:
转录因子SALL4通过影响pre-mRNA可变剪接调控非Yamanaka因子体细胞重编程的机制研究
-
批准号:32000502
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:王波
-
依托单位:
DNA糖苷酶OGG1调节PARP1介导的EB病毒潜伏蛋白表达的机制研究
-
批准号:32000546
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:郝文静
-
依托单位: